论文部分内容阅读
目的:探讨痰热清联合盐酸氨溴索氧气驱动雾化吸入治疗高海拔地区小儿肺炎的临床疗效。方法:将我院2013年1月—2015年1月收治100例肺炎患儿随机分为痰热清联合盐酸氨溴索氧气驱动雾化吸入组和常规治疗组,观察两组患儿的临床效果。结果:雾化吸入组患儿肺炎好转总有效率高于常规治疗组,雾化吸入组患儿咳嗽消失、体温正常、肺部啰音消失,临床症状改善情况良好。结论:采用痰热清联合盐酸氨溴索氧气驱动雾化吸入治疗小儿肺炎效果显著,不良反应少,易被患儿接受,值得在基层医院推广使用。
Objective: To investigate the clinical efficacy of Tanreqing combined with ambroxol hydrochloride aerosol inhalation in treating children pneumonia at high altitude. Methods: One hundred children with pneumonia admitted to our hospital from January 2013 to January 2015 were randomly divided into Tanreqing combined with ambroxol hydrochloride aerosol inhalation group and conventional treatment group, and the clinical effects of the two groups were observed . Results: The total effective rate of pneumonia improvement was higher in the atomized inhalation group than in the conventional treatment group. The children in the atomized inhalation group had disappeared cough, normal body temperature and pulmonary rales disappeared, and the clinical symptoms improved well. Conclusion: Tanreqing combined with ambroxol hydrochloride aerosol inhalation aerosol treatment of children with significant effect of pneumonia, fewer adverse reactions, easily accepted by children, it is worth to promote the use of primary hospitals.